| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A dual-luciferase bioluminescence system for the assessment of cellular therapies
|
Torres Chavez, Alejandro G.
|
|
|
32 |
1 |
p.
|
artikel
|
| 2 |
Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer
|
Nia, Giti Esmail
|
|
|
32 |
1 |
p.
|
artikel
|
| 3 |
Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer
|
Naik, Adviti
|
|
|
32 |
1 |
p.
|
artikel
|
| 4 |
CRISPR editing to mimic porphyria combined with light: A new preclinical approach for prostate cancer
|
Boutin, Julian
|
|
|
32 |
1 |
p.
|
artikel
|
| 5 |
Development of a novel, high-efficacy oncolytic herpes simplex virus type 1 platform equipped with two distinct retargeting modalities
|
Joo, Hyun-Yoo
|
|
|
32 |
1 |
p.
|
artikel
|
| 6 |
Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma
|
Yuen, John G.
|
|
|
32 |
1 |
p.
|
artikel
|
| 7 |
Differential landscape of immune evasion in oncogenic RAS-driven primary and metastatic colorectal cancers
|
Lou, Emil
|
|
|
32 |
1 |
p.
|
artikel
|
| 8 |
Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22
|
McComb, Scott
|
|
|
32 |
1 |
p.
|
artikel
|
| 9 |
Driving CAR-T cells toward solid lung tumors
|
Staal, Frank J.T.
|
|
|
32 |
1 |
p.
|
artikel
|
| 10 |
Emerging therapeutic approaches for peritoneal metastases from gastrointestinal cancers
|
Sikora, Aleksandra
|
|
|
32 |
1 |
p.
|
artikel
|
| 11 |
Empowering pancreatic tumor homing with augmented anti-tumor potency of CXCR2-tethered CAR-NK cells
|
Yoon, Jong Hyeon
|
|
|
32 |
1 |
p.
|
artikel
|
| 12 |
Engineering Proteus mirabilis improves antitumor efficacy via enhancing cytotoxic T cell responses
|
Zhang, Hong
|
|
|
32 |
1 |
p.
|
artikel
|
| 13 |
Gut microbiota composition is associated with the efficacy of Delta-24-RGDOX in malignant gliomas
|
Meléndez-Vázquez, Natalie M.
|
|
|
32 |
1 |
p.
|
artikel
|
| 14 |
Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy
|
Russo, Salvatore
|
|
|
32 |
1 |
p.
|
artikel
|
| 15 |
Mediation of antitumor activity by AZD4820 oncolytic vaccinia virus encoding IL-12
|
Kurokawa, Cheyne
|
|
|
32 |
1 |
p.
|
artikel
|
| 16 |
MicroRNA-34a-5p: A pivotal therapeutic target in gallbladder cancer
|
Oda, Takashi
|
|
|
32 |
1 |
p.
|
artikel
|
| 17 |
Minute virus of mice shows oncolytic activity against pancreatic cancer cells exhibiting a mesenchymal phenotype
|
Vienne, Margaux
|
|
|
32 |
1 |
p.
|
artikel
|
| 18 |
Noncoding RNA landscape and their emerging roles as biomarkers and therapeutic targets in meningioma
|
Joshi, Ritanksha
|
|
|
32 |
1 |
p.
|
artikel
|
| 19 |
Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors
|
Ingusci, Selene
|
|
|
32 |
1 |
p.
|
artikel
|
| 20 |
Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors
|
Troise, Fulvia
|
|
|
32 |
1 |
p.
|
artikel
|
| 21 |
Progress in sarcomas: Highlights from the 2023 annual meeting of the Connective Tissue Oncology Society
|
Cripe, Timothy P.
|
|
|
32 |
1 |
p.
|
artikel
|
| 22 |
Promising immunotherapy targets: TIM3, LAG3, and TIGIT joined the party
|
Lu, Chenyu
|
|
|
32 |
1 |
p.
|
artikel
|
| 23 |
Reviving the lost art of meeting reports
|
Cripe, Timothy P.
|
|
|
32 |
1 |
p.
|
artikel
|
| 24 |
Seek and destroy: Development of novel viral therapy for EGFR-expressing tumors
|
O’Connor, Christine
|
|
|
32 |
1 |
p.
|
artikel
|
| 25 |
Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunity
|
Wang, Dongjiao
|
|
|
32 |
1 |
p.
|
artikel
|
| 26 |
Targeting the ribosome to treat multiple myeloma
|
Maclachlan, Kylee H.
|
|
|
32 |
1 |
p.
|
artikel
|
| 27 |
TheraVision: Engineering platform technology for the development of oncolytic viruses based on herpes simplex virus type 1
|
Funk, Christina
|
|
|
32 |
1 |
p.
|
artikel
|
| 28 |
The 15th International Oncolytic Virotherapy Conference: Clinical successes point to a brighter future for cancer treatment
|
Rajwani, Jahanara
|
|
|
32 |
1 |
p.
|
artikel
|
| 29 |
TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs
|
Liao, Qingyu
|
|
|
32 |
1 |
p.
|
artikel
|
Tijdschrift beschrijving